Market Cap (In INR)
400.2 Billion
Revenue (In INR)
77.05 Billion
Net Income (In INR)
5.47 Billion
Avg. Volume
497.09 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1041.0-1708.65
- PE
- -
- EPS
- -
- Beta Value
- 0.229
- ISIN
- INE571A01038
- CUSIP
- Y4175R146
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Pranay Premchand Godha
- Employee Count
- -
- Website
- https://www.ipca.com
- Ipo Date
- 1996-01-01
- Details
- Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetology, gastroenterology, haematology, neurology, ophthalmology, rheumatology, and urology, as well as respiratory, psychiatry, probiotics, orthopedics, oral anti diabetes drug, nutraceuticals, NSAIDs, neuropathic pain, malaria, infectious diseases, immunosuppressant, hepatoprotectives, helminthics, fever, and emollients/protectives. It exports its products to approximately 100 countries worldwide. The company was incorporated in 1949 and is based in Mumbai, India.
More Stocks
-
ORIENTCEMOrient Cement Limited
ORIENTCEM
-
IFBC
-
OLATECHOlatech Solutions Limited
OLATECH
-
MEGASOFTMegasoft Limited
MEGASOFT
-
FIISO
-
1712
-
TLTFF
-
600165